查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049343

臨床試驗材料市場報告：按服務、階段、治療領域、最終用途行業和地區分類（2026-2034 年）

Clinical Trial Supplies Market Report by Services, Phase, Therapeutic Area (Oncology, Cardiovascular Diseases, Respiratory Diseases, Central Nervous System And Mental Disorders, and Others), End-Use Industry, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球臨床試驗材料市場規模達28億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到48億美元，2026年至2034年的複合年成長率（CAGR）為5.97%。慢性病盛行率的上升、監管改革的日益嚴格、臨床試驗的全球化、生物技術的進步、生物相似藥和孤兒藥的出現，以及區塊鏈和物聯網等創新技術在供應鏈管理中的應用，都在加速市場成長。

臨床試驗材料是指進行嚴格控制的醫學實驗以評估新藥、治療方法或醫療設備的安全性和有效性所必需的各種材料和資源。這些材料對於確保臨床試驗的順利進行至關重要，並為研究人員提供必要的工具和材料，以便他們進行治療、收集數據並遵守監管標準。臨床試驗材料包括臨床實驗藥物、安慰劑、醫療設備和生物檢體。其用途涵蓋從對受試者實施新的治療方法和介入措施到評估其治療效果。妥善控制的臨床試驗資料帶來的益處包括：維持試驗的盲法性、確保資料收集的準確性，並最終促進醫學知識的進步。

全球臨床試驗材料市場受慢性病盛行率上升和對創新治療方法的需求不斷成長的驅動。此外，旨在簡化藥物研發流程的監管改革和指南促使製藥公司加大對臨床試驗的投資，進一步推動市場成長。這導致臨床試驗全球化，旨在涵蓋不同的患者群體並進行成本效益高的試驗，從而增加了對試驗材料的需求並加速了市場成長。此外，生物技術和個人化醫療的進步增加了臨床試驗的複雜性，進一步推動了市場成長。而且，生物相似藥和孤兒藥的出現擴大了臨床試驗的範圍，這也推動了市場成長。

臨床試驗材料市場的趨勢與促進因素：

慢性病盛行率增加

癌症、糖尿病和心血管疾病等慢性病的日益增多是全球臨床試驗材料市場的重要促進因素。隨著人口老化和生活方式的改變，這些疾病在全球的盛行率持續上升。因此，製藥公司面臨研發新藥和新療法的壓力，導致臨床試驗數量激增。這一趨勢不僅推動了對臨床試驗材料的需求，也凸顯了高效能藥物研發流程對於應對這些健康挑戰的迫切性。此外，針對慢性病特定治療領域（例如腫瘤學和神經病學）的專用材料需求，加劇了供應鏈的複雜性，並已成為市場相關人員關注領域。

監理改革與指導方針

全球衛生當局和機構發布的監管改革和指南在推動臨床試驗材料市場發展方面發揮著至關重要的作用。這些法規旨在規範和加速藥物研發流程，同時確保病人安全。製藥和生物技術行業的公司必須遵守這些指南，這就要求進行嚴格合規的臨床試驗。因此，市場對符合監管要求的高品質耗材的需求日益成長。這不僅凸顯了遵守嚴格標準的重要性，也強調了高效率的供應鏈管理和文件記錄對於成功應對複雜的監管環境至關重要。

臨床試驗領域的變革

臨床試驗的全球化是推動臨床試驗材料市場發展的另一個主要因素。製藥公司擴大在多個國家進行試驗，以接觸不同的患者群體、加速受試者招募並降低成本。這一趨勢在新興市場尤其顯著，因為新興市場擁有大規模的患者群體。因此，全球對臨床試驗材料的需求不斷成長，不再局限於任何特定地區。這也凸顯了建立強大的物流和供應鏈網路的重要性，這些網路能夠有效率地支援在不同地理位置進行的試驗，而這些地區的監管要求往往各不相同。此外，全球化要求在語言、文化和當地基礎設施方面具備適應能力，這進一步增加了供應鏈管理流程的複雜性。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球臨床試驗材料市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依服務分類

  • 產品製造
  • 包裝、展示和存儲
  • 物流/配送

第7章 市場區隔：依階段分類

  • 第一階段
  • 第二階段
  • 第三階段
  • 其他

第8章 市場區隔：依治療領域分類

  • 腫瘤疾病
  • 心血管疾病
  • 呼吸系統疾病
  • 中樞神經系統和精神障礙
  • 其他

第9章 市場區隔：依最終用途產業分類

  • 醫療設備業
  • 生物製藥業
  • 製藥業
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Almac Group Ltd.
    • Catalent Pharma Solutions Inc.
    • DHL
    • Parexel
    • Thermo Fisher Scientific Inc.
    • PCI Services
    • Sharp Clinical
    • Biocair
    • Movianto
Product Code: SR112026A2104

The global clinical trial supplies market size reached USD 2.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 4.8 Billion by 2034, exhibiting a growth rate (CAGR) of 5.97% during 2026-2034. Increasing prevalence of chronic diseases, stringent regulatory reforms, the globalization of clinical trials, advancements in biotechnology, the emergence of biosimilars and orphan drugs, and the adoption of innovative technologies like blockchain and IoT for supply chain management are accelerating the market growth.

Clinical trial supplies encompass a wide range of materials and resources essential for conducting rigorous and controlled medical experiments to evaluate the safety and efficacy of new drugs, therapies, or medical devices. They are crucial in ensuring the smooth execution of clinical trials, providing researchers with the necessary tools and substances to administer treatments, collect data, and maintain compliance with regulatory standards. Clinical trial supplies consist of investigational drugs, placebos, medical devices, and biological samples. Their uses extend to the testing of novel treatments and interventions on human subjects to assess their therapeutic effects. Advantages of well-managed clinical trial supplies include the ability to maintain trial blinding, ensuring accurate data collection, and ultimately advancing medical knowledge.

The global clinical trial supplies market is influenced by the increasing prevalence of chronic diseases and the growing demand for innovative therapies. Moreover, regulatory reforms and guidelines aimed at streamlining the drug development process have prompted pharmaceutical companies to invest more in clinical trials, further propelling the market growth. In line with this, the globalization of clinical trials, driven by the pursuit of diverse patient populations and cost-effective operations, has created a greater need for trial supplies, which, in turn, is accelerating the market growth. Additionally, advancements in biotechnology and personalized medicine are increasing the complexity of clinical trials, further boosting the market growth. Apart from this, the emergence of biosimilars and orphan drugs has expanded the scope of clinical trials, which is fueling the market growth.

CLINICAL TRIAL SUPPLIES MARKET TRENDS/DRIVERS:

Increasing prevalence of chronic diseases

The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, is a significant driver of the global clinical trial supplies market. With an aging population and shifting lifestyle patterns, the prevalence of these conditions is steadily increasing worldwide. As a result, pharmaceutical companies are compelled to develop new drugs and therapies, necessitating an upsurge in clinical trials. This trend not only fuels the demand for clinical trial supplies but also underscores the urgency for effective and efficient drug development processes to address these health challenges. Furthermore, the need for specialized supplies for specific therapeutic areas within chronic diseases, like oncology or neurology, contributes to the complexity of the supply chain, making it a critical focus area for market players.

Regulatory reforms and guidelines

Regulatory reforms and guidelines issued by health authorities and agencies worldwide play a pivotal role in driving the clinical trial supplies market. These regulations aim to standardize and expedite the drug development process while ensuring patient safety. Companies operating in the pharmaceutical and biotechnology sectors must adhere to these guidelines, necessitating rigorous and compliant clinical trials. As a result, there is a growing demand for high-quality supplies to meet regulatory requirements. This driver not only underscores the importance of adherence to strict standards but also emphasizes the need for efficient supply chain management and documentation to navigate the complex regulatory landscape successfully.

Globalization of clinical trials

The globalization of clinical trials represents another key driver of the clinical trial supplies market. Pharmaceutical companies are increasingly conducting trials in multiple countries to access diverse patient populations, expedite recruitment, and reduce costs. This trend is especially pronounced in emerging markets with significant patient pools. Consequently, the demand for clinical trial supplies is not limited to a specific region but has expanded globally. This driver also highlights the need for robust logistics and supply chain networks that can efficiently support trials conducted in various geographical locations, often with differing regulatory requirements. Furthermore, globalization necessitates adaptability in terms of language, culture, and local infrastructure, adding complexity to the supply chain management process.

CLINICAL TRIAL SUPPLIES INDUSTRY SEGMENTATION:

Breakup by Services:

  • Product Manufacturing
  • Packaging, Labeling and Storage
  • Logistics and Distribution

Logistics and distribution dominates the market

The logistics and distribution segment within the clinical trial supplies market is witnessing substantial growth due to the increasing globalization of clinical trials. As pharmaceutical companies expand their trials to diverse geographic locations, the need for efficient and reliable logistics and distribution networks becomes paramount. This includes ensuring timely delivery of supplies to various trial sites worldwide. Moreover, advancements in technology, such as the integration of blockchain and IoT, are revolutionizing supply chain management. These innovations enhance real-time tracking and monitoring of clinical trial supplies, leading to increased efficiency and reduced wastage. In line with this, the COVID-19 pandemic has underscored the importance of resilient and adaptable supply chains. Companies are now investing in robust logistics to ensure the uninterrupted flow of critical supplies, even in times of crisis. Furthermore, the emphasis on patient-centric approaches in clinical trials has led to the need for patient kits and direct-to-patient shipments. This trend requires specialized logistics solutions tailored to individual patient needs.

Breakup by Phase :

  • Phase I
  • Phase II
  • Phase III
  • Others

Phase III dominates the market

The phase III segment dominates the market as it represents the pivotal stage in evaluating a drug's efficacy and safety, making it a critical step in the regulatory approval process. This regulatory focus drives pharmaceutical companies to invest significantly in phase III trials. Moreover, as drugs progress through earlier phases, the sample size required for phase III trials increases substantially, translating into higher demand for clinical trial supplies. Additionally, phase III trials often involve a global patient population, necessitating comprehensive supply chain logistics to ensure the timely delivery of materials to diverse sites. In line with this, the increasing complexity of drug development, particularly in areas like oncology and rare diseases, necessitates larger and more complex phase III trials. This complexity includes the need for specialized supplies, patient-centric approaches, and adaptive trial designs. Furthermore, the demand for phase III trials is influenced by market dynamics, including competition and the need for differentiation in therapeutic areas. Companies seek to demonstrate superior efficacy and safety profiles, making phase III trials a pivotal stage in their product development strategies.

Breakup by Therapeutic Area :

  • Oncology
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Central Nervous System (CNS) And Mental Disorders
  • Others

Oncology dominates the market

The oncology segment is experiencing significant growth within the clinical trial supplies market, primarily driven by the escalating global incidence of cancer. With cancer being one of the leading causes of mortality worldwide, pharmaceutical companies are increasingly investing in oncology-focused clinical trials to develop novel therapies and treatments. Moreover, advances in cancer research and the identification of specific biomarkers have led to the development of targeted therapies. This trend has necessitated the need for specialized clinical trial supplies tailored to the unique requirements of oncology trials, such as precision medicine tools and specialized diagnostics. Furthermore, regulatory agencies are expediting approvals for promising oncology drugs, encouraging pharmaceutical companies to accelerate their research efforts. Consequently, there is a growing demand for clinical trial supplies to support these fast-paced trials. Besides this, collaborations between pharmaceutical firms and academic institutions or research organizations are fostering innovation in oncology research. This partnership-driven approach is increasing the scope and complexity of clinical trials, thereby boosting the demand for clinical trial supplies.

Breakup by End-Use Industry :

  • Medical Device Industry
  • Biopharmaceuticals Industry
  • Pharmaceuticals Industry
  • Others

Pharmaceuticals industry hold the largest share in the market

The pharmaceuticals segment is experiencing substantial growth driven by the increasing global burden of chronic diseases, including cancer, cardiovascular ailments, and diabetes, which has led to a heightened demand for innovative drugs and therapies. Moreover, regulatory reforms and evolving healthcare policies are shaping the industry landscape. Stringent regulations and guidelines, particularly in developed markets, necessitate compliance and adherence to safety standards. This environment promotes innovation and the development of high-quality pharmaceutical products. Furthermore, advancements in biotechnology and genomics have ushered in an era of precision medicine. Tailoring treatments to individual patient profiles is becoming more common, driving research and development efforts in the pharmaceutical sector. Apart from this, the emergence of biosimilars and orphan drugs is expanding the pharmaceutical market's scope. Biosimilars offer cost-effective alternatives to biologics, while orphan drugs target rare diseases, presenting lucrative opportunities for pharmaceutical companies.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest clinical trial supplies market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represented the largest segment.

North America's clinical trial supplies market is witnessing substantial growth, fueled by the region's well-established pharmaceutical and biotechnology sector, coupled with a robust healthcare infrastructure, creates a conducive environment for clinical trials. Moreover, regulatory agencies like the FDA in the United States have streamlined approval processes, encouraging pharmaceutical companies to conduct trials in the region. In line with this, North America's diverse patient populations and access to specialized healthcare facilities make it an attractive destination for clinical trials across various therapeutic areas. Furthermore, the increasing prevalence of chronic diseases, such as diabetes and cancer, drives the demand for clinical trials to develop innovative treatments. Additionally, the emergence of cutting-edge technologies like genomics and precision medicine is propelling North America's position as a hub for advanced clinical research. The pandemic's impact has also accelerated the adoption of virtual and decentralized trials in the region, further contributing to market growth .

COMPETITIVE LANDSCAPE:

The competitive landscape of the clinical trial supplies market is characterized by a dynamic interplay of various stakeholders, each contributing to the industry's growth and evolution. Service providers in this sector offer a wide range of solutions, including clinical packaging, labeling, distribution, and logistics services, making it a highly specialized and competitive field. Key players in the market differentiate themselves through their global reach, technological capabilities, regulatory compliance, and ability to cater to diverse therapeutic areas. These companies often form strategic partnerships with pharmaceutical and biotechnology firms to provide end-to-end solutions for clinical trials. In addition to established companies, the market also sees the emergence of niche players focusing on specific areas such as direct-to-patient services, temperature-sensitive logistics, and innovative supply chain technologies. These specialized firms cater to the evolving needs of the industry, offering unique solutions to enhance efficiency and cost-effectiveness. Moreover, the market's competitive landscape is influenced by regulatory changes, as compliance with stringent standards is imperative. This factor underscores the importance of choosing suppliers with a proven track record in maintaining the highest quality and compliance levels.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Almac Group Ltd.
  • Catalent Pharma Solutions Inc.
  • DHL
  • Parexel
  • Thermo Fisher Scientific Inc.
  • PCI Services
  • Sharp Clinical
  • Biocair
  • Movianto

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How has the global clinical trial supplies market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global clinical trial supplies market?
  • What is the impact of each driver, restraint, and opportunity on the global clinical trial supplies market?
  • What are the key regional markets?
  • Which countries represent the most attractive clinical trial supplies market?
  • What is the breakup of the market based on the services?
  • Which are the most attractive services in the clinical trial supplies market?
  • What is the breakup of the market based on the phase?
  • Which is the most attractive phase in the clinical trial supplies market?
  • What is the breakup of the market based on the therapeutic area?
  • Which is the most attractive therapeutic area in the clinical trial supplies market?
  • What is the breakup of the market based on end-use industry?
  • Which is the most attractive end-use industry in the clinical trial supplies market?
  • What is the competitive structure of the global clinical trial supplies market?
  • Who are the key players/companies in the global clinical trial supplies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clinical Trial Supplies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Services

  • 6.1 Product Manufacturing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Packaging, Labeling and Storage
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Logistics and Distribution
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Phase

  • 7.1 Phase I
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Phase II
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Phase III
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Therapeutic Area

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiovascular Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Respiratory Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 CNS and Mental Disorders
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-Use Industry

  • 9.1 Medical Device Industry
    • 9.1.1 Market Trends
    • 9.1.3 Market Forecast
  • 9.2 Biopharmaceuticals Industry
    • 9.2.1 Market Trends
    • 9.2.3 Market Forecast
  • 9.3 Pharmaceuticals Industry
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.3 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Almac Group Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Catalent Pharma Solutions Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 DHL
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Parexel
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Thermo Fisher Scientific Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 PCI Services
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Sharp Clinical
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Biocair
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Movianto
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Clinical Trial Supplies Market: Major Drivers and Challenges
  • Figure 2: Global: Clinical Trial Supplies Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Clinical Trial Supplies Market: Breakup by Services (in %), 2025
  • Figure 4: Global: Clinical Trial Supplies Market: Breakup by Phase (in %), 2025
  • Figure 5: Global: Clinical Trial Supplies Market: Breakup by Therapeutic Area (in %), 2025
  • Figure 6: Global: Clinical Trial Supplies Market: Breakup by End-Use Industry (in %), 2025
  • Figure 7: Global: Clinical Trial Supplies Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Clinical Trial Supplies Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 9: Global: Clinical Trial Supplies (Product Manufacturing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Clinical Trial Supplies (Product Manufacturing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Clinical Trial Supplies (Packaging, Labeling and Storage) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Clinical Trial Supplies (Packaging, Labeling and Storage) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Clinical Trial Supplies (Logistics and Distribution) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Clinical Trial Supplies (Logistics and Distribution) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Clinical Trial Supplies (Phase I) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Clinical Trial Supplies (Phase I) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Clinical Trial Supplies (Phase II) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Clinical Trial Supplies (Phase II) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Clinical Trial Supplies (Phase III) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Clinical Trial Supplies (Phase III) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Clinical Trial Supplies (Oncology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Clinical Trial Supplies (Oncology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Clinical Trial Supplies (Cardiovascular Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Clinical Trial Supplies (Cardiovascular Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Clinical Trial Supplies (Respiratory Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Clinical Trial Supplies (Respiratory Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Clinical Trial Supplies (CNS and Mental Disorders) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Clinical Trial Supplies (CNS and Mental Disorders) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Clinical Trial Supplies (Medical Devices Industry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Clinical Trial Supplies (Medical Devices Industry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Clinical Trial Supplies (Biopharmaceuticals Industry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Clinical Trial Supplies (Biopharmaceuticals Industry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Clinical Trial Supplies (Pharmaceuticals Industry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Clinical Trial Supplies (Pharmaceuticals Industry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: North America: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: North America: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: United States: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: United States: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Canada: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Canada: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Asia Pacific: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Asia Pacific: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: China: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: China: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Japan: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Japan: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: India: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: India: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: South Korea: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: South Korea: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Australia: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Australia: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Indonesia: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Indonesia: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Others: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Europe: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Europe: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Germany: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Germany: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: France: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: France: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: United Kingdom: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: United Kingdom: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Italy: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Italy: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Spain: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Spain: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Russia: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Russia: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Others: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Latin America: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Latin America: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Brazil: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Brazil: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Mexico: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Mexico: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Others: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Middle East and Africa: Clinical Trial Supplies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Middle East and Africa: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Global: Clinical Trial Supplies Industry: SWOT Analysis
  • Figure 90: Global: Clinical Trial Supplies Industry: Value Chain Analysis
  • Figure 91: Global: Clinical Trial Supplies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clinical Trial Supplies Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Clinical Trial Supplies Market Forecast: Breakup by Services (in Million USD), 2026-2034
  • Table 3: Global: Clinical Trial Supplies Market Forecast: Breakup by Phase (in Million USD), 2026-2034
  • Table 4: Global: Clinical Trial Supplies Market Forecast: Breakup by Therapeutic Area (in Million USD), 2026-2034
  • Table 5: Global: Clinical Trial Supplies Market Forecast: Breakup by End-Use Industry (in Million USD), 2026-2034
  • Table 6: Global: Clinical Trial Supplies Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Clinical Trial Supplies Market: Competitive Structure
  • Table 8: Global: Clinical Trial Supplies Market: Key Players